Disease Info Card

Chronic Schizophrenia

Information about Chronic Schizophrenia: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Chronic Schizophrenia

Most recent studies have shown that Chronic Schizophrenia shares some biological mechanisms with anxiety-disorders, atrophy, bipolar-disorder, cognition-disorders, delusions, depressive-disorder, dyskinesia-drug-induced, dyskinetic-syndrome, extrapyramidal-sign, hallucinations, impaired-cognition, impairment-(finding), lingual-facial-buccal-dyskinesia, malnutrition, mental-disorders, mood-disorders, paranoid-schizophrenia, psychotic-disorders, schizoaffective-disorder, schizophrenia.

Among the many pathways, these few ones have gauged particular interests from scientists studying Chronic Schizophrenia, and have been seen in publications frequently: Aging, Brain Development, Cognition, Excretion, Growth Hormone Secretion, Habituation, Hormone Secretion, Hypersensitivity, Localization, Long-term Memory, Pathogenesis, Prepulse Inhibition, Prolactin Secretion, Reflex, Response To Clozapine, Secretion, Segmentation, Short-term Memory, Startle Response

Quite a number of genes have been found to play important roles in Chronic Schizophrenia, such as BDNF, COMT, CSF2, DBH, DIO2, EP300, GGH, GH1, IL2, IL6, INS, LAMC2, PBX1, POMC, PRL, SKAP2, TNF, TRH, USH1G. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.